Norepinephrine increases angiotensin II binding in rat brain synaptosomes.

Area of Science:

• Neuroscience
• Pharmacology
• Molecular Biology

Background:

• Angiotensin II (AII) receptors are present in rat hypothalamus and brainstem synaptosomes.
• Norepinephrine (NE) is a key neurotransmitter in the central nervous system.

Purpose of the Study:

• To investigate the effect of norepinephrine on angiotensin II binding in rat brain synaptosomes.
• To elucidate the receptor subtypes and signaling pathways involved in NE-mediated regulation of AII receptors.

Main Methods:

• Preparation of synaptosomes from rat hypothalamus and brainstem.
• Measurement of [125I]-angiotensin II specific binding after norepinephrine treatment.
• Use of alpha 1-adrenergic receptor antagonists (prazosin) and agonists.
• Assessment of protein kinase C (PKC) involvement using PKC activators (TPA) and inhibitors (H-7).

Main Results:

• Norepinephrine (NE) treatment increased the number of [125I]-AII binding sites in a concentration-dependent manner.
• The effect of NE was antagonized by prazosin, indicating alpha 1-adrenergic receptor involvement.
• PKC activation mimicked NE's effect, and PKC inhibition blocked it, suggesting a role for PKC signaling.

Conclusions:

• Norepinephrine modulates brain angiotensin II receptors through alpha 1-adrenergic receptors and protein kinase C.
• These findings support a role for catecholamines in regulating central angiotensin II receptor activity.
• The study provides evidence for NE's influence on AII receptor regulation in the brain.